{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:51:06Z","timestamp":1767646266961,"version":"3.48.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00894-025-06541-2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:29:25Z","timestamp":1764311365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of the inhibitor development for SARS-CoV-2: a systematic approach for drug design"],"prefix":"10.1007","volume":"31","author":[{"given":"Guangzhou","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanshan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"7798","key":"6541_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2202-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY et al (2020) A new coronavirus associated with human respiratory disease in China. Nature 579(7798):265\u2013269. https:\/\/doi.org\/10.1038\/s41586-020-2202-3","journal-title":"Nature"},{"key":"6541_CR2","unstructured":"World Health Organization (2020) D\u00e9pistage en laboratoire des cas suspects d\u2019infection humaine par le nouveau coronavirus 2019 (2019-nCoV): lignes directrices provisoires, 17 janvier 2020[M]. World Health Organization. https:\/\/covid19.who.int\/ . Accessed 15 Jan 2022"},{"issue":"12","key":"6541_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","volume":"8","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, Laggey J, Carrafiello PG, Carasana L, Rizzuto C et al (2020) Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. The lancet Resp med 8(12):1201\u20131208. https:\/\/doi.org\/10.1016\/S2213-2600(20)30370-2","journal-title":"The lancet Resp med"},{"key":"6541_CR4","doi-asserted-by":"crossref","unstructured":"Jebril1a NMT(2020) World Health Organization declared a pandemic public health menace: a systematic review of the coronavirus disease 2019 \u201cCOVID-19\u201d. International Journal of Psychosocial Rehabilitation 24(9). https:\/\/www.psychosocial.com\/article\/PR290311\/25748\/","DOI":"10.2139\/ssrn.3566298"},{"issue":"11","key":"6541_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu FF, Liu X, Zhang J, Wang BB, Xiang H, Cheng ZS, Xiong Y et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan China. JAMA 323(11):1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"issue":"7840","key":"6541_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","volume":"589","author":"Y Finkel","year":"2021","unstructured":"Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, Yahalom-Ronen Y, Tamir H, Achdoit H, Stein D, Israeli O et al (2021) The coding capacity of SARS-CoV-2. Nature 589(7840):125\u2013130. https:\/\/doi.org\/10.1038\/s41586-020-2739-1","journal-title":"Nature"},{"issue":"5","key":"6541_CR7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1042\/BCJ20200029","volume":"477","author":"B Krichel","year":"2020","unstructured":"Krichel B, Falke S, Hilgenfeld R, Redecke L, Uetrecht C (2020) Processing of the SARS-CoV pp1a\/ab nsp7-10 region. Biochem J 477(5):1009\u20131019. https:\/\/doi.org\/10.1042\/BCJ20200029","journal-title":"Biochem J"},{"issue":"7798","key":"6541_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"issue":"5626","key":"6541_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1085658","volume":"300","author":"K Anand","year":"2003","unstructured":"Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R (2003) Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300(5626):1763\u20131767. https:\/\/doi.org\/10.1126\/science.1085658","journal-title":"Science"},{"issue":"19","key":"6541_CR10","doi-asserted-by":"publisher","first-page":"9347","DOI":"10.1080\/07391102.2021.1927845","volume":"40","author":"J Novak","year":"2021","unstructured":"Novak J, Rimac H, Kandagalla S, Pathak P, Naumovich V, Grishina M, Potemkin V (2021) Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking. J Biomol Struct Dyn 40(19):9347\u20139360. https:\/\/doi.org\/10.1080\/07391102.2021.1927845","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"6541_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep22677","volume":"6","author":"F Wang","year":"2016","unstructured":"Wang F, Chen C, Tan W, Yang K, Yang H (2016) Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design. Sci Rep-UK 6(1):1\u201312. https:\/\/doi.org\/10.1038\/srep22677","journal-title":"Sci Rep-UK"},{"issue":"5","key":"6541_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/d41587-020-00005-z","volume":"38","author":"J Hodgson","year":"2020","unstructured":"Hodgson J (2020) The pandemic pipeline. Nat Biotechnol 38(5):523\u2013532. https:\/\/doi.org\/10.1038\/d41587-020-00005-z","journal-title":"Nat Biotechnol"},{"key":"6541_CR13","doi-asserted-by":"crossref","unstructured":"Patel CN, Jani SP, Jaiswal DG, Kumar SP, Mangukia N, Parmar RM, ..., Pandya HA (2021) Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations. Sci Rep 11(1):20295","DOI":"10.1038\/s41598-021-99165-4"},{"key":"6541_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.622898","volume":"9","author":"HM Mengist","year":"2021","unstructured":"Mengist HM, Dilnessa T, Jin T (2021) Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front Chem 9:622898. https:\/\/doi.org\/10.3389\/fchem.2021.622898","journal-title":"Front Chem"},{"key":"6541_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106318","volume":"151","author":"CN Patel","year":"2022","unstructured":"Patel CN, Jani SP, Kumar SP, Modi KM, Kumar Y (2022) Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus. Comput Biol Med 151:106318. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106318","journal-title":"Comput Biol Med"},{"issue":"14","key":"6541_CR16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJMc2112981","volume":"385","author":"J Keehner","year":"2021","unstructured":"Keehner J, Horton LE, Binkin NJ, Laurent LC, Pride D, Longhurst CA, Abeles SR, Torriani FJ (2021) Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. N Engl J Med 385(14):1330\u20131332. https:\/\/doi.org\/10.1056\/NEJMc2112981","journal-title":"N Engl J Med"},{"issue":"7811","key":"6541_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582(7811):289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"key":"6541_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coviro.2021.04.006","volume":"49","author":"K Vandyck","year":"2021","unstructured":"Vandyck K, Deval J (2021) Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection. Curr Opin Virol 49:36\u201340. https:\/\/doi.org\/10.1016\/j.coviro.2021.04.006","journal-title":"Curr Opin Virol"},{"key":"6541_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100794","volume":"59","author":"S Dro\u017cd\u017cal","year":"2021","unstructured":"Dro\u017cd\u017cal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyci\u0144ski J, Lorzadeh S, Kotfis K, Ghavami S, Los M (2021) An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Update 59:100794. https:\/\/doi.org\/10.1016\/j.drup.2021.100794","journal-title":"Drug Resist Update"},{"issue":"9","key":"6541_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s13238-021-00883-2","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Fang C, Zhang Q, Zhang R, Zhao X, Duan Y, Wang H, Zhu Y, Feng L, Zhao J et al (2022) Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332. Protein Cell 13(9):689\u2013693. https:\/\/doi.org\/10.1007\/s13238-021-00883-2","journal-title":"Protein Cell"},{"issue":"8","key":"6541_CR21","doi-asserted-by":"publisher","first-page":"e02013","DOI":"10.1128\/jvi.02013-21","volume":"96","author":"J Li","year":"2022","unstructured":"Li J, Lin C, Zhou X, Zhong F, Zeng P, Yang Y, Zhang Y, Yu B, Fan X, McCormick PJ et al (2022) Structural basis of the main proteases of coronavirus bound to drug candidate PF-07321332. J Virol 96(8):e02013\u2013e02021. https:\/\/doi.org\/10.1128\/jvi.02013-21","journal-title":"J Virol"},{"key":"6541_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2022.107692","volume":"99","author":"YJ Alvarado","year":"2022","unstructured":"Alvarado YJ, Olivarez Y, Lossada C, Vera-Villalobos J, Paz JL, Vera E, Lorono M, Vivas A, Torres FJ, Jeffreys LN et al (2022) Interaction of the new inhibitor Paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: a volumetric study based on molecular dynamics Elastic Networks Classical Thermodynamics and Spt. Comput Biol Chem 99:107692. https:\/\/doi.org\/10.1016\/j.compbiolchem.2022.107692","journal-title":"Comput Biol Chem"},{"key":"6541_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2021.108042","volume":"110","author":"M Macchiagodena","year":"2022","unstructured":"Macchiagodena M, Pagliai M, Procacci P (2022) Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease. J Mol Graph Model 110:108042. https:\/\/doi.org\/10.1016\/j.jmgm.2021.108042","journal-title":"J Mol Graph Model"},{"key":"6541_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2020.08.116","volume":"538","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Yin W, Xu HE (2021) RNA-dependent RNA polymerase: structure mechanism and drug discovery for COVID-19. Biochem Biophys Res Commun 538:47\u201353. https:\/\/doi.org\/10.1016\/j.bbrc.2020.08.116","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"6541_CR25","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/ced.15281","volume":"47","author":"M Pupo Correia","year":"2022","unstructured":"Pupo Correia M, Fernandes S, Filipe P (2022) Cutaneous adverse reactions to the new oral antiviral drugs against SARS-CoV-2. Clin Exp Dermatol 47(9):1738\u20131740. https:\/\/doi.org\/10.1111\/ced.15281","journal-title":"Clin Exp Dermatol"},{"issue":"13","key":"6541_CR26","doi-asserted-by":"publisher","first-page":"11287","DOI":"10.1021\/acs.chemrev.1c00965","volume":"122","author":"K Gao","year":"2022","unstructured":"Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW (2022) Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2. Chem Rev 122(13):11287\u201311368","journal-title":"Chem Rev"},{"issue":"4","key":"6541_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.14218\/JCTH.2021.00368","volume":"10","author":"R Zhang","year":"2022","unstructured":"Zhang R, Wang Q, Yang J (2022) Impact of liver functions by repurposed drugs for COVID-19 treatment. J Clin Transl Hepatol 10(4):748\u2013756. https:\/\/doi.org\/10.14218\/JCTH.2021.00368","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"6541_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/audiolres12030025","volume":"12","author":"MB Skarzynska","year":"2022","unstructured":"Skarzynska MB, Matusiak M, Skarzynski PH (2022) Adverse audio-vestibular effects of drugs and vaccines used in the treatment and prevention of COVID-19: a review. Audiol Res 12(3):224\u2013248. https:\/\/doi.org\/10.3390\/audiolres12030025","journal-title":"Audiol Res"},{"issue":"1","key":"6541_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jmv.1890150110","volume":"15","author":"TN Kaul","year":"1985","unstructured":"Kaul TN, Middleton JE, Ogra PL (1985) Antiviral effect of flavonoids on human viruses. J Med Virol 15(1):71\u201379. https:\/\/doi.org\/10.1002\/jmv.1890150110","journal-title":"J Med Virol"},{"key":"6541_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111998","volume":"142","author":"X Shen","year":"2021","unstructured":"Shen X, Yin F (2021) The mechanisms and clinical application of traditional Chinese medicine Lianhua-qingwen capsule. Biomed Pharmacother 142:111998. https:\/\/doi.org\/10.1016\/j.biopha.2021.111998","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"6541_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020612","volume":"99","author":"H Chen","year":"2020","unstructured":"Chen H, Song YP, Gao K, Zhao LT, Ma L (2020) Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19): a protocol of a systematic review and meta-analysis. Medicine 99(24):e20612. https:\/\/doi.org\/10.1097\/MD.0000000000020612","journal-title":"Medicine"},{"issue":"7","key":"6541_CR32","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.apsb.2020.06.009","volume":"10","author":"L Ni","year":"2020","unstructured":"Ni L, Chen L, Huang X, Han C, Xu J, Zhang H, Luan X, Zhao Y, Xu J, Yuan W et al (2020) Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm Sin B 10(7):1149\u20131162. https:\/\/doi.org\/10.1016\/j.apsb.2020.06.009","journal-title":"Acta Pharm Sin B"},{"issue":"42","key":"6541_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022715","volume":"99","author":"L Han","year":"2020","unstructured":"Han L, Wang Y, Hu K, Tang Z, Song X (2020) The therapeutic efficacy of Huashi Baidu Formula combined with antiviral drugs in the treatment of COVID-19: a protocol for systematic review and meta-analysis. Medicine 99(42):e22715. https:\/\/doi.org\/10.1097\/MD.0000000000022715","journal-title":"Medicine"},{"key":"6541_CR34","doi-asserted-by":"publisher","unstructured":"Guo H, Zheng J, Huang G, Xiang Y, Lang C, Li B, Huang D, Sun Q, Luo Y, Zhang Y et al (2020) Xuebijing injection in the treatment of COVID-19: a retrospective case-control study. Ann Palliat Med. 9(5):3235248\u20133233248. https:\/\/doi.org\/10.21037\/apm-20-1478","DOI":"10.21037\/apm-20-1478"},{"key":"6541_CR35","doi-asserted-by":"publisher","unstructured":"Xie L, Wang Y, Yin H, Li J, Xu Z, Sun Z, Liu F, Zhang X, Liu S, Sun J et al (2021) Identification of the absorbed ingredients and metabolites in rats after an intravenous administration of Tanreqing injection using high\u2010performance liquid chromatography coupled with quadrupole time\u2010of\u2010flight mass spectrometry. J Sep Sci 44(10):2097\u20132112. https:\/\/doi.org\/10.1002\/jssc.202000898","DOI":"10.1002\/jssc.202000898"},{"issue":"1","key":"6541_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-020-00375-1","volume":"15","author":"H Luo","year":"2020","unstructured":"Luo H, Gao Y, Zou J, Zhang S, Chen H, Liu Q, Tan D, Han Y, Zhao Y, Wang S (2020) Reflections on treatment of COVID-19 with traditional Chinese medicine. Chin Med-UK 15(1):1\u201314. https:\/\/doi.org\/10.1186\/s13020-020-00375-1","journal-title":"Chin Med-UK"},{"key":"6541_CR37","doi-asserted-by":"publisher","first-page":"110500","DOI":"10.1016\/j.biopha.2020.110500","volume":"129","author":"S Xin","year":"2020","unstructured":"Xin S, Cheng X, Zhu B, Liao X, Yang F, Song L, Shi Y, Guan X, Su R, Wang J (2020) Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with western medicine for COVID-19 treatment. Biomed & Pharmacother 129:110500. https:\/\/doi.org\/10.1016\/j.biopha.2020.110500","journal-title":"Biomed & Pharmacother"},{"issue":"8","key":"6541_CR38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/03639045.2020.1788070","volume":"46","author":"Q Tao","year":"2020","unstructured":"Tao Q, Du J, Li X, Zeng J, Tan B, Xu J, Lin W, Chen XL (2020) Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Drug Dev Ind Pharm 46(8):1345\u20131353. https:\/\/doi.org\/10.1080\/03639045.2020.1788070","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"6541_CR39","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S1875-5364(20)60038-3","volume":"18","author":"X Yan","year":"2019","unstructured":"Yan X, Ying-Rong HUA, Shang J, Wei-Hong GE, Jun LIAO (2019) Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019. Chin J Nat Medicines 18(12):941\u2013951. https:\/\/doi.org\/10.1016\/S1875-5364(20)60038-3","journal-title":"Chin J Nat Medicines"},{"key":"6541_CR40","doi-asserted-by":"publisher","unstructured":"Ren J, Zhang AH, Wang XJ (2020) Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res 155:104743. https:\/\/doi.org\/10.1016\/J.phrs.2020.104743","DOI":"10.1016\/J.phrs.2020.104743"},{"issue":"12","key":"6541_CR41","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1039\/C3FO60295H","volume":"4","author":"Y Hou","year":"2013","unstructured":"Hou Y, Jiang JG (2013) Origin and concept of medicine food homology and its application in modern functional foods. Food Funct 4(12):1727\u20131741. https:\/\/doi.org\/10.1039\/C3FO60295H","journal-title":"Food Funct"},{"key":"6541_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y et al (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:1\u20136. https:\/\/doi.org\/10.1186\/1758-2946-6-13","journal-title":"J Cheminform"},{"issue":"3","key":"6541_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/mp100465q","volume":"8","author":"L Chen","year":"2011","unstructured":"Chen L, Li Y, Zhao Q et al (2011) ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. Mol Pharm 8(3):889\u2013900","journal-title":"Mol Pharm"},{"key":"6541_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2015.05.011","volume":"582","author":"NM Cerqueira","year":"2015","unstructured":"Cerqueira NM, Gesto D, Oliveira EF, Santos-Martins D, Br\u00e1s NF, Sousa SF, Fernandes PA, Ramos MJ (2015) Receptor-based virtual screening protocol for drug discovery. Arch Biochem Biophys 582:56\u201367. https:\/\/doi.org\/10.1016\/j.abb.2015.05.011","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"6541_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jmgm.2014.11.015","volume":"56","author":"MA Islam","year":"2015","unstructured":"Islam MA, Pillay TS (2015) Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore virtual screening and molecular docking approaches for lead identification. J Mol Graph Model 56(2):20\u201330. https:\/\/doi.org\/10.1016\/j.jmgm.2014.11.015","journal-title":"J Mol Graph Model"},{"issue":"3","key":"6541_CR46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1039\/C5MB00767D","volume":"12","author":"MA Islam","year":"2016","unstructured":"Islam MA, Pillay TS (2016) Structural requirements for potential HIV-integrase inhibitors identified using pharmacophore-based virtual screening and molecular dynamics studies. Mol Biosyst 12(3):982\u2013993. https:\/\/doi.org\/10.1039\/C5MB00767D","journal-title":"Mol Biosyst"},{"key":"6541_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jmgm.2017.10.002","volume":"78","author":"W Du","year":"2017","unstructured":"Du W, Zuo K, Sun X, Liu W, Yan X, Liang L, Wan H, Chen F, Hu J (2017) An effective HIV-1 integrase inhibitor screening platform: rationality validation of drug screening conformational mobility and molecular recognition analysis for PFV integrase complex with viral DNA. J Mol Graph Model 78:96\u2013109. https:\/\/doi.org\/10.1016\/j.jmgm.2017.10.002","journal-title":"J Mol Graph Model"},{"issue":"6","key":"6541_CR48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/BF00124324","volume":"9","author":"G Jones","year":"1995","unstructured":"Jones G, Willett P, Glen RC (1995) A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J Comput Aided Mol Des 9(6):532\u2013549. https:\/\/doi.org\/10.1007\/BF00124324","journal-title":"J Comput Aided Mol Des"},{"key":"6541_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Autodock vina: improving the speed and accuracy of docking with a new scoring function efficient optimization and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"6541_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep15290","volume":"5","author":"J Li","year":"2015","unstructured":"Li J, Zhao P, Li Y, Tian Y, Wang Y (2015) Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease. Sci Rep 5:15290. https:\/\/doi.org\/10.1038\/srep15290","journal-title":"Sci Rep"},{"issue":"6","key":"6541_CR51","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/ijms13066964","volume":"13","author":"X Xu","year":"2012","unstructured":"Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan J, Yang L (2012) A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci 13(6):6964\u20136982. https:\/\/doi.org\/10.3390\/ijms13066964","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6541_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","volume":"145","author":"W Tao","year":"2013","unstructured":"Tao W, Xu X, Wang X, Li B, Wang Y, Li Y, Yang L (2013) Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal radix curcumae formula for application to cardiovascular disease. J Ethnopharmacol 145(1):1\u201310. https:\/\/doi.org\/10.1016\/j.jep.2012.09.051","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"6541_CR53","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1021\/acs.jcim.9b00445","volume":"59","author":"R Kong","year":"2019","unstructured":"Kong R, Wang F, Zhang J, Wang F, Chang S (2019) CoDockPP: a multistage approach for global and site-specific protein\u2013protein docking. J Chem Inf Model 59(8):3556\u20133564. https:\/\/doi.org\/10.1021\/acs.jcim.9b00445","journal-title":"J Chem Inf Model"},{"key":"6541_CR54","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"issue":"2","key":"6541_CR55","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"issue":"8","key":"6541_CR56","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto S, Kollman PA (1992) Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13(8):952\u2013962. https:\/\/doi.org\/10.1002\/jcc.540130805","journal-title":"J Comput Chem"},{"issue":"1","key":"6541_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD-Visual molecular dynamics. J Mol Graph 14(1):33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"issue":"10","key":"6541_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076045","volume":"8","author":"H Wan","year":"2013","unstructured":"Wan H, Hu J, Li K, Tian XH, Chang S (2013) Molecular dynamics simulations of DNA-free and DNA-bound TAL effectors. PLoS ONE 8(10):e76045. https:\/\/doi.org\/10.1371\/journal.pone.0076045","journal-title":"PLoS ONE"},{"issue":"9","key":"6541_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/08927022.2019.1579327","volume":"45","author":"H Duan","year":"2019","unstructured":"Duan H, Liu X, Zhuo W, Meng J, Gu J, Sun X, Zuo K, Luo Q, Luo Y, Tang D et al (2019) 3D-QSAR and molecular recognition of Klebsiella pneumoniae NDM-1 inhibitors. Mol Simul 45(9):694\u2013705. https:\/\/doi.org\/10.1080\/08927022.2019.1579327","journal-title":"Mol Simul"},{"issue":"5","key":"6541_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jmgm.2003.12.005","volume":"22","author":"M Feig","year":"2004","unstructured":"Feig M, Karanicolas J, Brooks IIICL (2004) MMTSB tool set: enhanced sampling and multiscale modeling methods for applications in structural biology. J Mol Graph Model 22(5):377\u2013395. https:\/\/doi.org\/10.1016\/j.jmgm.2003.12.005","journal-title":"J Mol Graph Model"},{"issue":"12","key":"6541_CR61","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W et al (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33(12):889\u2013897. https:\/\/doi.org\/10.1021\/ar000033j","journal-title":"Acc Chem Res"},{"issue":"2","key":"6541_CR62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0959-440X(00)00197-4","volume":"11","author":"T Simonson","year":"2001","unstructured":"Simonson T (2001) Macromolecular electrostatics: continuum models and their growing pains. Curr Opin Struct Biol 11(2):243\u2013252. https:\/\/doi.org\/10.1016\/S0959-440X(00)00197-4","journal-title":"Curr Opin Struct Biol"},{"issue":"2","key":"6541_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"J Welser","year":"1999","unstructured":"Welser J, Shenkin PS, Still WC (1999) Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem 20(2):217\u2013230. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(19990130)20:2%3c217::AID-JCC4%3e3.0.CO;2-A","journal-title":"J Comput Chem"},{"key":"6541_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154481","volume":"107","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhang Y, Wang D, Yang B, Shen YQ (2022) Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine. Phytomedicine 107:154481. https:\/\/doi.org\/10.1016\/j.phymed.2022.154481","journal-title":"Phytomedicine"},{"issue":"4","key":"6541_CR65","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/ci200617d","volume":"52","author":"A Hamza","year":"2012","unstructured":"Hamza A, Wei NN, Zhan CG (2012) Ligand-based virtual screening approach using a new scoring function. J Chem Inf Model 52(4):963\u2013974. https:\/\/doi.org\/10.1021\/ci200617d","journal-title":"J Chem Inf Model"},{"issue":"5","key":"6541_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050761","volume":"18","author":"K Zuo","year":"2017","unstructured":"Zuo K, Liang L, Du W, Sun X, Liu W, Gou X, Wan H, Hu J (2017) 3D-QSAR molecular docking and molecular dynamics simulation of Pseudomonas aeruginosa LpxC inhibitors. Int J Mol Sci 18(5):761. https:\/\/doi.org\/10.3390\/ijms18050761","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6541_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-022-00074-3","volume":"3","author":"D Guo","year":"2022","unstructured":"Guo D, Duan H, Cheng Y, Wang Y, Hu J, Shi H (2022) Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies. Mol Biomed 3(1):1\u201318. https:\/\/doi.org\/10.1186\/s43556-022-00074-3","journal-title":"Mol Biomed"},{"key":"6541_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112044","volume":"242","author":"L Ren","year":"2019","unstructured":"Ren L, Zheng X, Liu J, Li W, Fu W, Tang Q, Wang J, Du G (2019) Network pharmacology study of traditional Chinese medicines for stroke treatment and effective constituents screening. J Ethnopharmacol 242:112044. https:\/\/doi.org\/10.1016\/j.jep.2019.112044","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"6541_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102148","volume":"24","author":"Z Li","year":"2021","unstructured":"Li Z, Yao Y, Cheng X, Chen Q, Zhao W, Ma S, Li Z, Zhou H, Li W, Fei T (2021) A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses. iScience 24(3):102148. https:\/\/doi.org\/10.1016\/j.isci.2021.102148","journal-title":"iScience"},{"issue":"3","key":"6541_CR70","doi-asserted-by":"publisher","first-page":"2100002","DOI":"10.1002\/minf.202100002","volume":"41","author":"X Li","year":"2022","unstructured":"Li X, Jiang Q, Yang X (2022) Discovery of inhibitors for mycobacterium tuberculosis peptide deformylase based on virtual screening in silico. Mol Inform 41(3):2100002. https:\/\/doi.org\/10.1002\/minf.202100002","journal-title":"Mol Inform"},{"issue":"1","key":"6541_CR71","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1080\/14756366.2021.1954919","volume":"36","author":"M Pavan","year":"2021","unstructured":"Pavan M, Bolcato G, Bassani D, Sturlese M, Moro S (2021) Supervised molecular dynamics (SuMD) insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332. J Enzym Inhib Med Chem 36(1):1645\u20131649. https:\/\/doi.org\/10.1080\/14756366.2021.1954919","journal-title":"J Enzym Inhib Med Chem"},{"issue":"3","key":"6541_CR72","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jep.2013.02.004","volume":"146","author":"H Liu","year":"2013","unstructured":"Liu H, Wang J, Zhou W, Wang Y, Yang L (2013) Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J Ethnopharmacol 146(3):773\u2013793. https:\/\/doi.org\/10.1016\/j.jep.2013.02.004","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"6541_CR73","doi-asserted-by":"publisher","first-page":"e12949","DOI":"10.1111\/cpr.12949","volume":"53","author":"QD Xia","year":"2020","unstructured":"Xia QD, Xun Y, Lu JL, Lu YC, Yang YY, Zhou P, Hu J, Li C, Wang SG (2020) Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19. Cell Prolif 53(12):e12949. https:\/\/doi.org\/10.1111\/cpr.12949","journal-title":"Cell Prolif"},{"key":"6541_CR74","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11655-020-3476-x","volume":"26","author":"L Gao","year":"2020","unstructured":"Gao L, Xu J, Chen S (2020) In silico screening of potential Chinese herbal medicine against COVID-19 by targeting SARS-CoV-2 3CLpro and angiotensin converting enzyme II using molecular docking. Chin J Integr Med 26:527\u2013532. https:\/\/doi.org\/10.1007\/s11655-020-3476-x","journal-title":"Chin J Integr Med"},{"issue":"24","key":"6541_CR75","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020531","volume":"99","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Cao F, Wang Y, Xu X, Sun Y, Li J, Qi X, Sun S, Ji G, Song B (2020) The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): a protocol for systematic review and meta analysis. Medicine (Baltimore) 99(24):e20531. https:\/\/doi.org\/10.1097\/MD.0000000000020531","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6541_CR76","doi-asserted-by":"publisher","first-page":"731765","DOI":"10.1155\/2015\/731765","volume":"2015","author":"W Jia","year":"2015","unstructured":"Jia W, Wang C, Wang Y, Pan G, Jiang M, Li Z, Zhu Y (2015) Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS. Sci World J 2015(1):731765. https:\/\/doi.org\/10.1155\/2015\/731765","journal-title":"Sci World J"},{"key":"6541_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113871","volume":"273","author":"S Jia","year":"2021","unstructured":"Jia S, Luo H, Liu X, Fan X, Huang Z, Lu S, Shen L, Guo S, Liu Y, Wang Z et al (2021) Dissecting the novel mechanism of Reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification. J Ethnopharmacol 273:113871. https:\/\/doi.org\/10.1016\/j.jep.2021.113871","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"6541_CR78","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1875-5364(16)30091-7","volume":"14","author":"F Zhang","year":"2016","unstructured":"Zhang F, Liang SUN, Shou-Hong GAO, Wan-Sheng CHEN, Yi-Feng CHAI (2016) LC-MS\/MS analysis and pharmacokinetic study on five bioactive constituents of Tanreqing injection in rats. Chin J Nat Medicines 14(10):769\u2013775. https:\/\/doi.org\/10.1016\/S1875-5364(16)30091-7","journal-title":"Chin J Nat Medicines"},{"issue":"1","key":"6541_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-021-00427-0","volume":"16","author":"S Xia","year":"2021","unstructured":"Xia S, Zhong Z, Gao B, Vong CT, Lin X, Cai J, Gao H, Chan G, Li C (2021) The important herbal pair for the treatment of COVID-19 and its possible mechanisms. Chin Med-UK 16(1):1\u201316. https:\/\/doi.org\/10.1186\/s13020-021-00427-0","journal-title":"Chin Med-UK"},{"issue":"9","key":"6541_CR80","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jsps.2020.08.002","volume":"28","author":"T He","year":"2020","unstructured":"He T, Qu R, Qin C, Wang Z, Zhang Y, Shao X, Lu T (2020) Potential mechanisms of Chinese herbal medicine that implicated in the treatment of COVID-19 related renal injury. Saudi Pharm J 28(9):1138\u20131148","journal-title":"Saudi Pharm J"},{"issue":"1","key":"6541_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11096-020-01153-7","volume":"43","author":"C Wang","year":"2021","unstructured":"Wang C, Sun S, Ding X (2021) The therapeutic effects of traditional Chinese medicine on COVID-19: a narrative review. Int J Clin Pharm-Net 43(1):35\u201345. https:\/\/doi.org\/10.1007\/s11096-020-01153-7","journal-title":"Int J Clin Pharm-Net"},{"issue":"8","key":"6541_CR82","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.7150\/ijms.53685","volume":"18","author":"X Zhang","year":"2021","unstructured":"Zhang X, Gao R, Zhou Z, Tang X, Lin J, Wang L, Zhou X, Shen TA (2021) Network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19. Int J Med Sci 18(8):1866. https:\/\/doi.org\/10.7150\/ijms.53685","journal-title":"Int J Med Sci"},{"issue":"3","key":"6541_CR83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11655-022-3686-5","volume":"29","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Xu H, Qu Z, Ma XY, Huang BX, Sun MS, Wang BQ, Wang GY (2023) Active ingredients of Reduning injections maintain high potency against SARS-CoV-2 variants. Chin J Integr Med 29(3):205\u2013212. https:\/\/doi.org\/10.1007\/s11655-022-3686-5","journal-title":"Chin J Integr Med"},{"key":"6541_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153401","volume":"85","author":"M Ye","year":"2021","unstructured":"Ye M, Luo G, Ye D, She M, Sun N, Lu YJ, Zheng J (2021) Network pharmacology molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie quwen granules against coronavirus disease 2019 pneumonia. Phytomedicine 85:153401. https:\/\/doi.org\/10.1016\/j.phymed.2020.153401","journal-title":"Phytomedicine"},{"issue":"1","key":"6541_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69337-9","volume":"10","author":"R Yoshino","year":"2020","unstructured":"Yoshino R, Yasuo N, Sekijima M (2020) Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates. Sci Rep 10(1):12493. https:\/\/doi.org\/10.1038\/s41598-020-69337-9","journal-title":"Sci Rep"},{"issue":"2\u20133","key":"6541_CR86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bpc.2007.09.008","volume":"132","author":"JP Hu","year":"2008","unstructured":"Hu JP, Gong XQ, Su JG, Zu Chen W, Wang CX (2008) Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach. Biophys Chem 132(2\u20133):69\u201380. https:\/\/doi.org\/10.1016\/j.bpc.2007.09.008","journal-title":"Biophys Chem"},{"key":"6541_CR87","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) Ligplot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci200227u","journal-title":"J Chem Inf Model"},{"key":"6541_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105468","volume":"145","author":"A Parihar","year":"2022","unstructured":"Parihar A, Sonia ZF, Akter F, Ali MA, Hakim FT, Hossain MS (2022) Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: a promising therapeutic approach for tackling COVID-19. Comput Biol Med 145:105468. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105468","journal-title":"Comput Biol Med"},{"issue":"13","key":"6541_CR89","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.88.138101","volume":"88","author":"M Tarek","year":"2002","unstructured":"Tarek M, Tobias DJ (2002) Role of protein-water hydrogen bond dynamics in the protein dynamical transition. Phys Rev Lett 88(13):138101. https:\/\/doi.org\/10.1103\/PhysRevLett.88.138101","journal-title":"Phys Rev Lett"},{"issue":"1","key":"6541_CR90","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","volume":"11","author":"DW Kneller","year":"2020","unstructured":"Kneller DW, Phillips G, O\u2019Neill HM, Jedrzejczak R, Stols L, Langan P, Joachimiak A, Coates L, Kovalevsky A (2020) Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nat Commun 11(1):3202. https:\/\/doi.org\/10.1038\/s41467-020-16954-7","journal-title":"Nat Commun"},{"issue":"13","key":"6541_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137048","volume":"22","author":"F Mangiavacchi","year":"2021","unstructured":"Mangiavacchi F, Botwina P, Menichetti E, Bagnoli L, Rosati O, Marini F, Fonseca SF, Abenante L, Alves D, Dabrowska A et al (2021) Seleno-functionalization of quercetin improves the non-covalent inhibition of Mpro and its antiviral activity in cells against SARS-CoV-2. Int J Mol Sci 22(13):7048. https:\/\/doi.org\/10.3390\/ijms22137048","journal-title":"Int J Mol Sci"},{"key":"6541_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.705252","volume":"12","author":"B Zhou","year":"2021","unstructured":"Zhou B, Yuan Y, Shi L, Hu S, Wang D, Yang Y, Pan Y, Kong D, Shikov AN, Duez P et al (2021) Creation of an anti-inflammatory leptin-dependent anti-obesity celastrol mimic with better druggability. Front Pharmacol 12:705252. https:\/\/doi.org\/10.3389\/fphar.2021.705252","journal-title":"Front Pharmacol"},{"issue":"6","key":"6541_CR93","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/2211-5463.12875","volume":"10","author":"M Tsuji","year":"2020","unstructured":"Tsuji M (2020) Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease. FEBS Open Bio 10(6):995\u20131004","journal-title":"FEBS Open Bio"},{"issue":"D1","key":"6541_CR94","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B et al (2023) PubChem 2023 update. Nucleic Acids Res 51(D1):D1373\u2013D1380. https:\/\/doi.org\/10.1093\/nar\/gkac956","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6541_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open babel: an open chemical toolbox. J Cheminform 3(1):1\u201314. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"issue":"13","key":"6541_CR96","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Morley C, Vandermeersch T, Hutchison GR (2004) UCSF chimera-a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"6541_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115922","volume":"440","author":"D Hoer","year":"2022","unstructured":"Hoer D, Barton HA, Paini A, Bartels M, Ingle B, Domoradzki J, Fisher J, Embry M, Villanueva P, Miller D et al (2022) Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling. Toxicol Appl Pharm 440:115922. https:\/\/doi.org\/10.1016\/j.taap.2022.115922","journal-title":"Toxicol Appl Pharm"},{"key":"6541_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, Lu AP, Cao DS (2018) ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J cheminformatics 10:1\u201311. https:\/\/doi.org\/10.1186\/s13321-018-0283-x","journal-title":"J cheminformatics"},{"issue":"1","key":"6541_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"6541_CR100","doi-asserted-by":"publisher","unstructured":"Stork C, Chen Y, Sicho M, Kirchmair J (2019) Hit Dexter 2.0: machine-learning models for the prediction of frequent hitters. J Chem Inf Model 59(3):1030\u20131043.https:\/\/doi.org\/10.1021\/acs.jcim.8b00677","DOI":"10.1021\/acs.jcim.8b00677"},{"issue":"12","key":"6541_CR101","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1080\/07391102.2021.1872419","volume":"40","author":"S Shah","year":"2022","unstructured":"Shah S, Chaple D, Arora S, Yende S, Mehta C, Nayak U (2022) Prospecting for cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2. J Biomol Struct Dyn 40(12):5643\u20135652. https:\/\/doi.org\/10.1080\/07391102.2021.1872419","journal-title":"J Biomol Struct Dyn"},{"key":"6541_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.692168","volume":"9","author":"JC Ferreira","year":"2021","unstructured":"Ferreira JC, Fadl S, Villanueva AJ, Rabeh WM (2021) Catalytic dyad residues His41 and Cys145 impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease. Front Chem 9:692168. https:\/\/doi.org\/10.3389\/fchem.2021.692168","journal-title":"Front Chem"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06541-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-025-06541-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06541-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:34:45Z","timestamp":1767638085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-025-06541-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":102,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6541"],"URL":"https:\/\/doi.org\/10.1007\/s00894-025-06541-2","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"type":"print","value":"1610-2940"},{"type":"electronic","value":"0948-5023"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the affiliations of author.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}